文献速递静脉血栓栓塞慢性静脉疾病

机械血栓清除术与抗凝治疗对髂股深静脉血栓的疗效比较

Comparison of anticoagulation vs mechanical thrombectomy for the treatment of iliofemoral deep vein thrombosis.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2024-01-24

本研究基于ATTRACT随机试验与CLOUT注册研究,通过倾向性评分1:1匹配164对髂股深静脉血栓患者,比较机械血栓清除术(MT)与抗凝治疗(AC)对Villalta评分及血栓后综合征(PTS)发生率的影响。结果显示,MT组在6个月和12个月的PTS发生率均显著低于AC组,且Villalta评分更低;校正基线评分后,AC组发生任何PTS及中重度PTS的比值比均显著升高。

要点

  • 匹配后MT组6个月PTS发生率19%,AC组46%(P < .001)。
  • 匹配后MT组12个月PTS发生率17%,AC组38%(P < .001)。
  • 校正基线Villalta评分后,AC组12个月任何PTS的OR为3.1(95%CI 1.5-6.2;P = .002),中重度PTS的OR为3.1(95%CI 1.1-8.4;P = .027)。

核心结论

  • 与抗凝治疗相比,机械血栓清除术治疗髂股深静脉血栓与12个月内更低的Villalta评分和更低的PTS发生率相关。
  • 目前正在招募的临床试验结果将进一步明确这些疗法在急性深静脉血栓后预防PTS中的作用。

研究设计与样本

  • 本研究纳入ATTRACT随机试验和CLOUT注册研究中髂股深静脉血栓患者进行分析。
  • 排除双侧DVT、孤立性股腘DVT、症状持续时间>4周或匹配协变量数据不完整的患者。
  • 采用倾向性评分最近邻匹配法,按9项基线协变量(年龄、体重指数、治疗侧、诱发性DVT、既往静脉血栓栓塞、种族、性别、Villalta评分、症状持续时间)将接受抗凝治疗(来自ATTRACT)与机械血栓清除术(来自CLOUT)的患者1:1匹配。
  • 共匹配164对,匹配后基线特征无显著差异。
  • 采用逻辑回归估计12个月发生PTS的可能性。

主要发现

  • MT组6个月任何PTS发生率19%,AC组46%(P < .001)。
  • MT组12个月任何PTS发生率17%,AC组38%(P < .001)。
  • 校正基线Villalta评分后,AC组12个月发生任何PTS的OR为3.1(95%CI 1.5-6.2;P = .002),中重度PTS的OR为3.1(95%CI 1.1-8.4;P = .027),均高于MT组。
  • MT组与AC组平均Villalta评分:30天为3.3 vs 6.3,6个月为2.5 vs 5.5,12个月为2.6 vs 4.9(所有P < .001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the comparative effects of treatment with contemporary mechanical thrombectomy (MT) or anticoagulation (AC) on Villalta scores and post-thrombotic syndrome (PTS) incidence through 12 months in iliofemoral deep vein thrombosis (DVT). METHODS: Patients with DVT in the Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis (ATTRACT) randomized trial and the ClotTriever Outcomes (CLOUT) registry were included in this analysis. Both studies evaluated the effects of thrombus removal on the incidence of PTS. Patients with bilateral DVT, isolated femoral-popliteal DVT, symptom duration of >4 weeks, or incomplete case data for matching covariates were excluded. Propensity scores were used to match patients 1:1 who received AC (from ATTRACT) with those treated with mechanical thrombectomy (from CLOUT) using nearest neighbor matching on nine baseline covariates, including age, body mass index, leg treated, provoked DVT, prior venous thromboembolism, race, sex, Villalta score, and symptom duration. Clinical outcomes, including Villalta score and PTS, were assessed. Logistic regression was used to estimate the likelihood of developing PTS at 12 months. RESULTS: A total of 164 pairs were matched, with no significant differences in baseline characteristics after matching. There were fewer patients with any PTS at 6 months (19% vs 46%; P < .001) and 12 months (17% vs 38%; P < .001) in the MT treatment group. Modeling revealed that, after adjusting for baseline Villalta scores, patients treated with AC had significantly higher odds of developing any PTS (odds ratio, 3.1; 95% confidence interval, 1.5-6.2; P = .002) or moderate to severe PTS (odds ratio, 3.1; 95% confidence interval, 1.1-8.4; P = .027) at 12 months compared with those treated with MT. Mean Villalta scores were lower through 12 months among those receiving MT vs AC (3.3 vs 6.3 at 30 days, 2.5 vs 5.5 at 6 months, and 2.6 vs 4.9 at 12 months; P < .001 for all). CONCLUSIONS: MT treatment of iliofemoral DVT was associated with significantly lower Villalta scores and a lower incidence of PTS through 12 months compared with treatment using AC. Results from currently enrolling clinical trials will further clarify the role of these therapies in the prevention of PTS after an acute DVT event.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Abramowitz S, Shaikh A, Mojibian H, et al. Comparison of anticoagulation vs mechanical thrombectomy for the treatment of iliofemoral deep vein thrombosis. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 38278173. doi:10.1016/j.jvsv.2024.101825

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。